Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Association between XPF polymorphisms and cancer risk: a meta-analysis.

Shi TY, He J, Qiu LX, Zhu ML, Wang MY, Zhou XY, Han J, Yu H, Zang RY, Wei Q.

PLoS One. 2012;7(7):e38606. doi: 10.1371/journal.pone.0038606. Epub 2012 Jul 2. Review.

2.

Lack of association between XPF polymorphisms and gastric cancer risk: a meta-analysis.

Lin J, Hu B, Wang M.

Oncol Res Treat. 2014;37(10):546-52. doi: 10.1159/000367801. Epub 2014 Sep 16.

PMID:
25342505
3.

Effect of Xeroderma pigmentosum complementation group F polymorphisms on gastric cancer risk and associations with H.pylori infection.

Zhang JS, Zhang C, Yan XY, Yuan ZF, Duan ZY, Gao H.

Asian Pac J Cancer Prev. 2013;14(3):1847-50.

4.

Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.

Ding DP, He XF, Zhang Y.

Breast Cancer Res Treat. 2011 Aug;129(1):203-9. doi: 10.1007/s10549-011-1447-9. Epub 2011 Mar 22.

PMID:
21424776
5.

XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis.

Mei J, Duan HX, Wang LL, Yang S, Lu JQ, Shi TY, Zhao Y.

Tumour Biol. 2014 Feb;35(2):1221-31. doi: 10.1007/s13277-013-1163-7. Epub 2013 Sep 21.

PMID:
24057881
6.
7.

Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck.

Yu H, Liu Z, Huang YJ, Yin M, Wang LE, Wei Q.

PLoS One. 2012;7(7):e41853. doi: 10.1371/journal.pone.0041853. Epub 2012 Jul 27.

8.

Association of polymorphisms of the xeroderma pigmentosum complementation group F gene with increased glioma risk.

Zhou WK, Huang LY, Hui L, Wang ZW, Jin BZ, Zhao XL, Zhang XZ, Wang JX, Wang JC, Wang RZ.

Genet Mol Res. 2014 May 16;13(2):3826-31. doi: 10.4238/2014.May.16.7.

9.

Effects of polymorphisms in nucleotide excision repair genes on glioma risk in a Chinese population.

Wang XF, Liu S, Shao ZK.

Gene. 2013 Oct 25;529(2):317-20. doi: 10.1016/j.gene.2013.07.025. Epub 2013 Jul 31.

PMID:
23911298
10.

A novel XPF -357A>C polymorphism predicts risk and recurrence of bladder cancer.

Wang M, Wang M, Yuan L, Wu D, Zhang Z, Yin C, Fu G, Wei Q, Zhang Z.

Oncogene. 2010 Apr 1;29(13):1920-8. doi: 10.1038/onc.2009.484. Epub 2010 Jan 11.

PMID:
20062074
11.

Association between the XPG Asp1104His and XPF Arg415Gln polymorphisms and risk of cancer: a meta-analysis.

He XF, Liu LR, Wei W, Liu Y, Su J, Wang SL, Shen XL, Yang XB.

PLoS One. 2014 May 6;9(5):e88490. doi: 10.1371/journal.pone.0088490. eCollection 2014.

12.

Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.

Yang Z, Fang X, Pei X, Li H.

Genet Test Mol Biomarkers. 2013 Sep;17(9):700-6. doi: 10.1089/gtmb.2013.0122. Epub 2013 Aug 2.

13.

Association of XPF Levels and Genetic Polymorphism with Susceptibility to Ischemic Stroke.

Ma Y, Deng XD, Feng Y, Zhang W, Wang SX, Liu Y, Liu H.

J Mol Neurosci. 2016 May;59(1):168-76. doi: 10.1007/s12031-016-0729-4. Epub 2016 Feb 18.

PMID:
26888738
14.

Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.

Zhu ML, Hua RX, Zheng L.

Tumour Biol. 2014 Apr;35(4):2931-9. doi: 10.1007/s13277-013-1377-8. Epub 2013 Dec 28.

PMID:
24375193
15.

The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analysis of 28 case-control studies.

Huang SX, Wu FX, Luo M, Ma L, Gao KF, Li J, Wu WJ, Huang S, Yang Q, Liu K, Zhao YN, Li LQ.

PLoS One. 2013;8(2):e56722. doi: 10.1371/journal.pone.0056722. Epub 2013 Feb 21.

16.

Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.

Fleming ND, Agadjanian H, Nassanian H, Miller CW, Orsulic S, Karlan BY, Walsh CS.

Cancer. 2012 Feb 1;118(3):689-97. doi: 10.1002/cncr.26329. Epub 2011 Jul 12. Erratum in: Cancer. 2012 Nov 1;118(21):5450.

17.

XPF-673C>T polymorphism effect on the susceptibility to esophageal cancer in Chinese population.

Liu Y, Cao L, Chang J, Lin J, He B, Rao J, Zhang Z, Zhang X.

PLoS One. 2014 Apr 7;9(4):e94136. doi: 10.1371/journal.pone.0094136. eCollection 2014.

18.

Association of single nucleotide polymorphisms of ERCC1 and XPF with colorectal cancer risk and interaction with tobacco use.

Hou R, Liu Y, Feng Y, Sun L, Shu Z, Zhao J, Yang S.

Gene. 2014 Sep 10;548(1):1-5. doi: 10.1016/j.gene.2014.05.025. Epub 2014 May 23.

PMID:
24861646
19.

Polymorphisms in excision repair cross-complementing group 4 (ERCC4) and susceptibility to primary lung cancer in a Chinese Han population.

Shao M, Ma H, Wang Y, Xu L, Yuan J, Wang Y, Hu Z, Yang L, Wang F, Liu H, Qian J, Xun P, Chen W, Yuan W, Jing G, Chen F, Jin L, Wei Q, Wu T, Shen H, Huang W, Lu D.

Lung Cancer. 2008 Jun;60(3):332-9. Epub 2008 Feb 20.

PMID:
18068852
20.

Lack of association between Bax promoter (-248G>A) single nucleotide polymorphism and susceptibility towards cancer: evidence from a meta-analysis.

Sahu SK, Choudhuri T.

PLoS One. 2013 Oct 17;8(10):e77534. doi: 10.1371/journal.pone.0077534. eCollection 2013.

Supplemental Content

Support Center